HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fabiola M Ribeiro Selected Research

VU0409106

1/2021Negative Modulation of the Metabotropic Glutamate Receptor Type 5 as a Potential Therapeutic Strategy in Obesity and Binge-Like Eating Behavior.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fabiola M Ribeiro Research Topics

Disease

12Huntington Disease (Huntington's Disease)
01/2022 - 01/2010
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 01/2010
5Alzheimer Disease (Alzheimer's Disease)
12/2020 - 03/2008
3Inflammation (Inflammations)
01/2021 - 01/2018
2AIDS-Related Complex (ARC)
01/2022 - 10/2018
2Obesity
01/2022 - 01/2021
2Microcephaly
01/2019 - 01/2017
2Infections
11/2018 - 01/2017
2Zika Virus Infection
11/2018 - 01/2017
1Body Weight (Weight, Body)
01/2021
1Cognitive Dysfunction
01/2021
1Prodromal Symptoms
01/2021
1Weight Loss (Weight Reduction)
01/2021
1Neuroinflammatory Diseases
01/2019
1Virus Diseases (Viral Diseases)
11/2018
1Memory Disorders (Memory Loss)
10/2018
1Guillain-Barre Syndrome
01/2017
1Parkinson Disease (Parkinson's Disease)
02/2013
1Epilepsy (Aura)
02/2013
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2013
1Substance-Related Disorders (Drug Abuse)
02/2013
1Multiple Sclerosis
02/2013
1Ischemia
11/2012
1Brain Diseases (Brain Disorder)
11/2010

Drug/Important Bio-Agent (IBA)

5Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2021 - 01/2010
4Metabotropic Glutamate 5 ReceptorIBA
01/2022 - 04/2014
4polyglutamineIBA
01/2017 - 01/2010
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 10/2018
2Peptides (Polypeptides)IBA
11/2018 - 01/2018
2Glutamic Acid (Glutamate)FDA Link
01/2018 - 11/2014
2Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2014
2Cholinergic Agents (Cholinergics)IBA
01/2016 - 03/2008
2Huntingtin ProteinIBA
04/2014 - 01/2010
1Inositol (Myoinositol)IBA
01/2021
1VU0409106IBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
12/2020
1CateninsIBA
01/2020
1Cadherins (E-Cadherin)IBA
01/2020
1Calcium Channels (Calcium Channel)IBA
01/2019
1ChemokinesIBA
01/2019
1Antiviral Agents (Antivirals)IBA
11/2018
1VU0409551IBA
10/2018
1Syntaxin 1IBA
10/2018
1VenomsIBA
01/2018
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2018
1Ion Channels (Ion Channel)IBA
01/2018
1Protein AggregatesIBA
01/2018
1Axonemal DyneinsIBA
12/2017
1Biomarkers (Surrogate Marker)IBA
12/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017
1Pharmaceutical PreparationsIBA
01/2017
1Neuroprotective AgentsIBA
01/2017
1Memantine (Namenda)FDA Link
01/2017
1N-Methylaspartate (NMDA)IBA
01/2017
1CalciumIBA
01/2016
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
02/2013
1Glutamate Receptors (Glutamate Receptor)IBA
11/2012
1metabotropic glutamate receptor type 1IBA
11/2010
1Oxygen (Dioxygen)IBA
03/2008
1Reactive Nitrogen SpeciesIBA
03/2008
1Peroxynitrous Acid (Peroxynitrite)IBA
03/2008
1Superoxides (Superoxide)IBA
03/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2008

Therapy/Procedure

3Therapeutics
01/2021 - 01/2017
1Drug Therapy (Chemotherapy)
01/2021